We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$910M
AUM Growth
-$293M
Cap. Flow
-$291M
Cap. Flow %
-31.96%
Top 10 Hldgs %
72.57%
Holding
111
New
6
Increased
25
Reduced
42
Closed
28
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$349B
$3.93M 0.43%
49,473
-5,452
-10% -$417K
IEFA icon
27
iShares Core MSCI EAFE ETF
IEFA
$186B
$3.53M 0.39%
64,836
+3,300
+5% +$183K
IWN icon
28
iShares Russell 2000 Value ETF
IWN
$14.4B
$2.79M 0.31%
30,351
+21,994
+263% +$2.09M
EFV icon
29
iShares MSCI EAFE Value ETF
EFV
$26B
$2.61M 0.29%
56,099
+9,211
+20% +$445K
EFA icon
30
iShares MSCI EAFE ETF
EFA
$76.5B
$2.51M 0.28%
42,710
+2,425
+6% +$146K
AMJ
31
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$2.46M 0.27%
84,878
-90,963
-52% -$2.79M
BND icon
32
Vanguard Total Bond Market
BND
$159B
$2.18M 0.24%
26,966
-376
-1% -$30.6K
GWX icon
33
State Street SPDR S&P International Small Cap ETF
GWX
$856M
$1.94M 0.21%
68,779
+8,312
+14% +$239K
SUB icon
34
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$1.88M 0.21%
17,750
-49,114
-73% -$5.2M
GSP
35
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
$1.72M 0.19%
132,415
-431,300
-77% -$6.42M
AAPL icon
36
Apple
AAPL
$4.9T
$1.66M 0.18%
63,060
+12,172
+24% +$348K
HYG icon
37
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.61M 0.18%
20,043
+8,272
+70% +$688K
BRK.A icon
38
Berkshire Hathaway Class A
BRK.A
$1.06T
$1.58M 0.17%
8
EFAV icon
39
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.23B
$1.43M 0.16%
22,023
+12,877
+141% +$839K
MUB icon
40
iShares National Muni Bond ETF
MUB
$45.5B
$1.4M 0.15%
12,613
-3,794
-23% -$416K
USMV icon
41
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$1.25M 0.14%
29,794
-10,841
-27% -$452K
IGSB icon
42
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$1.22M 0.13%
23,346
-5,904
-20% -$310K
VTI icon
43
Vanguard Total Stock Market ETF
VTI
$658B
$1.1M 0.12%
10,509
-20,358
-66% -$2.14M
IWM icon
44
iShares Russell 2000 ETF
IWM
$82.2B
$1.02M 0.11%
9,058
-134
-1% -$15.5K
VEA icon
45
Vanguard FTSE Developed Markets ETF
VEA
$226B
$987K 0.11%
26,885
-30,030
-53% -$1.13M
IWR icon
46
iShares Russell Mid-Cap ETF
IWR
$56.6B
$874K 0.1%
21,820
+4,144
+23% +$169K
VBK icon
47
Vanguard Small-Cap Growth ETF
VBK
$23.4B
$853K 0.09%
7,024
-14,979
-68% -$1.85M
ACWI icon
48
iShares MSCI ACWI ETF
ACWI
$32.8B
$841K 0.09%
15,072
+4,705
+45% +$269K
VV icon
49
Vanguard Large-Cap ETF
VV
$52.2B
$706K 0.08%
7,550
-16,150
-68% -$1.52M
WEN icon
50
Wendy's
WEN
$1.48B
$691K 0.08%
64,196
-128,594
-67% -$1.27M

Similar funds

Aspiriant LLC's Q4 2015 Portfolio in Review

As of Q4 2015, Aspiriant LLC held 111 positions worth $910M, down 24% from $1.2B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Aspiriant LLC withdrew a net $291M in Q4 2015, closing 28 positions and reducing 42 holdings. Its most notable exit was ExxonMobil, an estimated $2.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 2.8% of assets, up from 2.6% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Aspiriant LLC opened a new position in Vanguard High Dividend Yield ETF worth $399K.

  • Aspiriant LLC's largest Q4 2015 buy was Vanguard High Dividend Yield ETF: 5,985 shares worth $399K.
  • Aspiriant LLC added most to iShares MSCI Global Min Vol Factor ETF in Q4 2015, an estimated $23.8M increase.
  • Aspiriant LLC's biggest Q4 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $101M.
  • Aspiriant LLC fully exited ExxonMobil in Q4 2015, selling an estimated $2.2M.
  • Aspiriant LLC's ten largest holdings make up 73% of its $910M portfolio in Q4 2015.
  • Aspiriant LLC opened 6 new positions and closed 28 in Q4 2015.
  • Aspiriant LLC's portfolio value fell 24% quarter-over-quarter to $910M.

Based on Aspiriant LLC's 13F filing for Q4 2015, filed 8 Feb 2016.